Live Breaking News & Updates on Ultragenyx pharmaceutical inc

Stay informed with the latest breaking news from Ultragenyx pharmaceutical inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ultragenyx pharmaceutical inc and stay connected to the pulse of your community

Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease

Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Bedford , Massachusetts , Canada , Boston , America , Carolyn-wang , Joshua-higa , Emil-kakkis , Translational-sciences , Exchange-commission

TD Cowen Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00

Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) had its price objective increased by TD Cowen from $59.00 to $61.00 in a report released on Wednesday, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other research analysts have also recently issued reports on RARE. Wedbush reissued a neutral rating […]

United-states , Japan , Canada , America , Robertw-baird , Dekabank-deutsche-girozentrale , Thomas-richard-kassberg , Charles-schwab-investment-management-inc , Jpmorgan-chase-co , Cantor-fitzgerald , Royal-bank , Deutsche-bank

Ultragenyx Pharmaceutical (NASDAQ:RARE) Coverage Initiated by Analysts at Royal Bank of Canada

Royal Bank of Canada began coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage issued an outperform rating and a $77.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently commented on RARE. JPMorgan Chase & Co. upped their […]

United-states , Canada , Arizona , Japan , America , Robertw-baird , Karah-herdman-parschauer , Royal-bank , Allspring-global-investments-holdings , Securities-exchange-commission , Covestor-ltd , Associates-corp

Ultragenyx Pharmaceutical (RARE) to Release Quarterly Earnings on Thursday

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) will issue its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of ($1.73) per share for the quarter. Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The biopharmaceutical company […]

United-states , Japan , Canada , America , Matthewk-fust , Cantor-fitzgerald , Royal-bank , Ultragenyx-pharmaceutical-inc , Canaccord-genuity-group , Nasdaq , Ultragenyx-pharmaceutical-company-profile

Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update

NOVATO, Calif., April 25, 2024 -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare...

Carolyn-wang , Joshua-higa , Ultragenyx-pharmaceutical-inc , Nasdaq , Markets ,

Ultragenyx to Host Conference Call for First Quarter 2024

NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...

Carolyn-wang , Joshua-higa , Ultragenyx-pharmaceutical-inc , Nasdaq , Nasdaq-rare , Ltragenyx-pharmaceutical-inc- ,

Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by Royal Bank of Canada

Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by Royal Bank of Canada
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China , Canada , Japan , United-states , America , Robertw-baird , Thomas-richard-kassberg , Canaccord-genuity-group , Royal-bank , Nasdaq , China-universal-asset-management-co , Cantor-fitzgerald

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Netherlands , Malvern , Worcestershire , United-kingdom , United-states , Cambridge , Cambridgeshire , Harvard-university , Massachusetts , Boston , California

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Japan , Canada , China , United-states , America , Robertw-baird , Thomas-richard-kassberg , Cantor-fitzgerald , China-universal-asset-management-co , Ultragenyx-pharmaceutical-inc , Canaccord-genuity-group , Securities-exchange-commission

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $61.00 at TD Cowen

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $61.00 at TD Cowen
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Japan , Canada , America , Thomas-richard-kassberg , Robertw-baird , Royal-bank , Associates-corp , Securities-exchange-commission , International-assets-investment-management , Covestor-ltd , Cantor-fitzgerald